134 related articles for article (PubMed ID: 9640366)
1. The intradermal effects of the H3 receptor agonist R alpha methylhistamine in human skin.
Kavanagh GM; Sabroe RA; Greaves MW; Archer CB
Br J Dermatol; 1998 Apr; 138(4):622-6. PubMed ID: 9640366
[TBL] [Abstract][Full Text] [Related]
2. Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Sansom JE; Brooks J; Burton JL; Archer CB
Clin Exp Dermatol; 1996 Jan; 21(1):33-7. PubMed ID: 8689766
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of R-alpha-methylhistamine, a selective histamine H3 receptor agonist, in rats: lack of involvement of histamine H3 receptors.
Hegde SS; Chan P; Eglen RM
Eur J Pharmacol; 1994 Jan; 251(1):43-51. PubMed ID: 7907986
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
Cardell LO; Edvinsson L
Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
[TBL] [Abstract][Full Text] [Related]
5. The effects of topical doxepin on responses to histamine, substance P and prostaglandin E2 in human skin.
Sabroe RA; Kennedy CT; Archer CB
Br J Dermatol; 1997 Sep; 137(3):386-90. PubMed ID: 9349334
[TBL] [Abstract][Full Text] [Related]
6. Production by R-alpha-methylhistamine of a histamine H3 receptor-mediated decrease in basal vascular resistance in guinea-pigs.
McLeod RL; Gertner SB; Hey JA
Br J Pharmacol; 1993 Oct; 110(2):553-8. PubMed ID: 7902173
[TBL] [Abstract][Full Text] [Related]
7. Characterization of histamine receptor sub-types regulating prostacyclin release from human endothelial cells.
Bull HA; Courtney PF; Rustin MH; Dowd PM
Br J Pharmacol; 1992 Oct; 107(2):276-81. PubMed ID: 1330171
[TBL] [Abstract][Full Text] [Related]
8. Effects of H1 antagonists on the cutaneous vascular response to histamine and bradykinin: a study using scanning laser Doppler imaging.
Clough GF; Bennett AR; Church MK
Br J Dermatol; 1998 May; 138(5):806-14. PubMed ID: 9666826
[TBL] [Abstract][Full Text] [Related]
9. Effects of histamine receptor antagonists on histamine-induced responses in human skin.
Hägermark O; Strandberg K; Grönneberg R
Acta Derm Venereol; 1979; 59(4):297-300. PubMed ID: 92142
[TBL] [Abstract][Full Text] [Related]
10. Dose-response relationship between objective measures of histamine-induced weals and dose of terfenadine.
Shall L; Newcombe RG; Lush M; Marks R
Acta Derm Venereol; 1991; 71(3):199-204. PubMed ID: 1678220
[TBL] [Abstract][Full Text] [Related]
11. N alpha-methylhistamine inhibits intestinal transit in mice by central histamine H1 receptor activation.
Oishi R; Adachi N; Saeki K
Eur J Pharmacol; 1993 Jun; 237(2-3):155-9. PubMed ID: 8103457
[TBL] [Abstract][Full Text] [Related]
12. Histamine H3 receptor activation inhibits sympathetic-cholinergic responses in cats.
Koss MC
Eur J Pharmacol; 1994 May; 257(1-2):109-15. PubMed ID: 8082690
[TBL] [Abstract][Full Text] [Related]
13. Effects of the histamine H3-agonist (R)-alpha-methylhistamine and the antagonist thioperamide on histamine metabolism in the mouse and rat brain.
Oishi R; Itoh Y; Nishibori M; Saeki K
J Neurochem; 1989 May; 52(5):1388-92. PubMed ID: 2540269
[TBL] [Abstract][Full Text] [Related]
14. Agonist-antagonist interactions in the skin: comparison of effects of loratadine and cetirizine on skin vascular responses to prick tests with histamine and substance P.
Van Neste D; Coussement C; Ghys L; Rihoux JP
J Dermatol Sci; 1992 Nov; 4(3):172-9. PubMed ID: 1283698
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive instrumental techniques to detect terfenadine and temelastine induced suppression of histamine weals in man.
Shall L; Marks R
Br J Clin Pharmacol; 1987 Oct; 24(4):409-13. PubMed ID: 2891368
[TBL] [Abstract][Full Text] [Related]
16. Inhibition by glucocorticoids of the mast cell-dependent weal and flare response in human skin in vivo.
Cole ZA; Clough GF; Church MK
Br J Pharmacol; 2001 Jan; 132(1):286-92. PubMed ID: 11156588
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological activity of VUF 9153, an isothiourea histamine H3 receptor antagonist.
Barnes JC; Brown JD; Clarke NP; Clapham J; Evans DJ; O'Shaughnessy CT
Eur J Pharmacol; 1993 Nov; 250(1):147-52. PubMed ID: 8119312
[TBL] [Abstract][Full Text] [Related]
18. Autoregulation of histamine release via the histamine H3 receptor on mast cells in the rat skin.
Ohkubo T; Shibata M; Inoue M; Kaya H; Takahashi H
Arch Int Pharmacodyn Ther; 1994; 328(3):307-14. PubMed ID: 7542864
[TBL] [Abstract][Full Text] [Related]
19. Histamine H3 receptor-mediated inhibition of sympathetically evoked mydriasis in rats.
Yu Y; Kawarai M; Koss MC
Eur J Pharmacol; 2001 May; 419(1):55-9. PubMed ID: 11348630
[TBL] [Abstract][Full Text] [Related]
20. Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: substance P role in peripheral inflammation in mice.
Fernández-Dueñas V; Ciruela F; Gandía J; Sánchez S; Planas E; Poveda R
Eur J Pharmacol; 2010 Jul; 638(1-3):72-7. PubMed ID: 20435034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
